81 related articles for article (PubMed ID: 12548436)
1. Intra-erythrocyte deposition of growth hormone in rheumatic diseases.
Denko CW; Boja B; Malemud CJ
Rheumatol Int; 2003 Jan; 23(1):11-4. PubMed ID: 12548436
[TBL] [Abstract][Full Text] [Related]
2. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
Denko CW; Malemud CJ
Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
[TBL] [Abstract][Full Text] [Related]
3. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis--insulin, insulin-like growth factor-I, growth hormone.
Denko CW; Boja B; Moskowitz RW
J Rheumatol; 1994 Sep; 21(9):1725-30. PubMed ID: 7799357
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
[TBL] [Abstract][Full Text] [Related]
5. Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders.
Denko CW; Boja B; Moskowitz RW
Osteoarthritis Cartilage; 1996 Dec; 4(4):245-9. PubMed ID: 11048621
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH).
Denko CW; Boja B; Malemud CJ
Front Biosci; 2002 Apr; 7():a37-43. PubMed ID: 11897552
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
Denko CW; Malemud CJ
Rheumatol Int; 2006 Feb; 26(4):292-7. PubMed ID: 15703952
[TBL] [Abstract][Full Text] [Related]
9. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis.
Rovensky J; Imrich R; Malis F; Zlnay M; Macho L; Koska J; Vigas M
J Rheumatol; 2004 Dec; 31(12):2418-21. PubMed ID: 15570644
[TBL] [Abstract][Full Text] [Related]
11. Study of axial bone mineral density in postmenopausal women with diffuse idiopathic skeletal hyperostosis related to type 2 diabetes mellitus.
Sahin G; Polat G; Bagis S; Milcan A; Erdogan C
J Womens Health (Larchmt); 2002 Nov; 11(9):801-4. PubMed ID: 12626079
[TBL] [Abstract][Full Text] [Related]
12. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome.
Vriezekolk JE; Geenen R; Hartkamp A; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
J Rheumatol; 2005 Dec; 32(12):2351-5. PubMed ID: 16331762
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls.
Taiym S; Haghighat N; Al-Hashimi I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):579-83. PubMed ID: 15153869
[TBL] [Abstract][Full Text] [Related]
14. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
15. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Skowronski J; Cylwik JP; Cylwik B; Chwiecko J
J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis.
Mader R; Novofestovski I; Adawi M; Lavi I
Semin Arthritis Rheum; 2009 Apr; 38(5):361-5. PubMed ID: 18304611
[TBL] [Abstract][Full Text] [Related]
17. [Serum adiponectin levels in patients with acromegaly].
Siemińska L; Lenart J; Cichoń-Lenart A; Niedziołka D; Marek B; Kos-Kudła B; Kajdaniuk D; Nowak M
Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte sedimentation rate within rheumatic disease clinics.
Giacomello A; Quaratino CP; Zoppini A
J Rheumatol; 1997 Nov; 24(11):2263-5. PubMed ID: 9375897
[No Abstract] [Full Text] [Related]
19. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
[TBL] [Abstract][Full Text] [Related]
20. Circulating nucleic acids in the assessment of endogenous growth hormone production.
Thakkar H; Butt AN; Powrie J; Holt R; Swaminathan R
Ann N Y Acad Sci; 2008 Aug; 1137():58-65. PubMed ID: 18837926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
